Indian Council of Medical Research (ICMR) has received royalty of Rs. 171.74 crore till 31st January, 2022 from Bharat Biotech from the sales of COVID vaccine Covaxin. The Council has spent around Rs. 35 crore in research and development of Covaxin.

Funds with ICMR are utilised for health research activities, including emerging research priorities and research capacity building, the Health Ministry told the Upper House of Parliament on Tuesday in response to a question by LoP Mallikarjun Kharge.

Health Minister Mansukh Mandaviya said 1,616 claims have been settled as per the State/Union Territories-wise details of compensation paid to the families of deceased health workers.
